1.Refined correction method of unilateral cleft lip nasal deformity.
Yeon Chul JUNG ; jin Hwan KIM ; Rong Min BAEK ; Kab Sung OH ; Se Min BAEK
Journal of the Korean Society of Plastic and Reconstructive Surgeons 1993;20(5):1006-1013
No abstract available.
Cleft Lip*
;
Congenital Abnormalities*
2.Recent Advances in Core Needle Biopsy for Thyroid Nodules.
Chan Kwon JUNG ; Jung Hwan BAEK
Endocrinology and Metabolism 2017;32(4):407-412
Core needle biopsy (CNB) was introduced as an alternative diagnostic tool to fine-needle aspiration (FNA), and is increasingly being used in the preoperative assessment of thyroid nodules. CNB provides a definitive diagnosis in most cases, but it sometimes may be inconclusive. CNB has the advantage of enabling a histologic examination in relation to the surrounding thyroid tissue, immunohistochemistry, and molecular testing that can provide a more accurate assessment than FNA in selected cases. Nevertheless, CNB should be performed only by experienced experts in thyroid interventions to prevent complications because CNB needles are larger in caliber than FNA needles. As recent evidence has accumulated, and with improvements in the technique and devices for thyroid CNB, the Korean Society of Thyroid Radiology released its 2016 thyroid CNB guidelines and the Korean Endocrine Pathology Thyroid Core Needle Biopsy Study Group published a consensus statement on the pathology reporting system for thyroid CNB in 2015. This review presents the current consensus and recommendations regarding thyroid CNB, focusing on indications, complications, and pathologic classification and reporting.
Biopsy, Fine-Needle
;
Biopsy, Large-Core Needle*
;
Biopsy, Needle
;
Classification
;
Consensus
;
Diagnosis
;
Immunohistochemistry
;
Needles
;
Pathology
;
Thyroid Gland*
;
Thyroid Nodule*
3.Effects of Phospholipase A2 Inhibitor, Ochnaflavone, on the TNF-alpha and NO Production in Macrophages.
Jung Hee KIM ; Chul JIN ; Jung Gil HONG ; Pan Gil SEO ; Suk Hwan BAEK
Korean Journal of Immunology 2000;22(3):157-163
No abstract available.
Macrophages*
;
Phospholipases A2*
;
Phospholipases*
;
Tumor Necrosis Factor-alpha*
4.Long-Term Outcomes Following Thermal Ablation of Benign Thyroid Nodules as an Alternative to Surgery: The Importance of Controlling Regrowth
Endocrinology and Metabolism 2019;34(2):117-123
Thermal ablation (TA) procedures, such as radiofrequency ablation and laser ablation, are used for the treatment of benign thyroid nodules. Short-term studies (<2 years) have demonstrated that TA is an effective and safe procedure to improve cosmetic or symptomatic problems. However, studies including a longer follow-up period show that treated thyroid nodules can increase in size after 2 to 3 years. Several studies suggest that this results from regrowth at the undertreated nodule margins. Here, we review current data on regrowth after TA and describe factors related to it and possible approaches to prevent it.
Catheter Ablation
;
Follow-Up Studies
;
Laser Therapy
;
Thyroid Gland
;
Thyroid Nodule
5.Response: Long-Term Outcomes Following Thermal Ablation of Benign Thyroid Nodules as an Alternative to Surgery: The Importance of Controlling Regrowth (Endocrinol Metab 2019;34:117–23, Jung Suk Sim et al.)
Endocrinology and Metabolism 2019;34(3):325-326
No abstract available.
Thyroid Gland
;
Thyroid Nodule
9.Forehead augmentation with hydroxyapatite.
Yeon Chul JUNG ; Jae Hyun PARK ; Jin Hwan KIM ; Rong Min BAEK ; Kap Sung OH ; Se Min BAEK
Journal of the Korean Society of Plastic and Reconstructive Surgeons 1993;20(5):1039-1048
No abstract available.
Durapatite*
;
Forehead*
10.A Comparative Study the USA, Europe and Korea Guidelines of Antiplatelet Therapy for Patients with Acute Coronary Syndrome.
Eun Joo JUNG ; Chae Won LEE ; In Hwan BAEK
Korean Journal of Clinical Pharmacy 2015;25(3):200-208
OBJECTIVE: Patients with acute coronary syndrome (ACS) are typically managed with dual antiplatelet therapy of acetylsalicylic acid (aspirin) and P2Y12 receptor inhibitor. In this study, we discussed current and previous antiplatelet therapy guidelines and compared with guidelines of the USA (ACC/AHA), Europe (ESC) and Korea (KSC). METHOD: This study investigated from ACC/AHA Joint Guidelines (the USA), ESC Clinical Practice Guidelines (Europe) and Korea Society of Interventional Cardiology (Korea) web site, respectively. RESULTS: It is significant that difference between the current and the previous guidelines was integration of terminology from clopidogrel to P2Y12 receptor inhibitors since prasugrel and ticagrelor, new antiplatelet drugs, has been added. The other difference was all three guidelines has differences in dose of aspirin. The most notable difference was class of recommendation (COR) in P2Y12 receptor inhibitors. ACC/AHA and Korean guidelines recommend clopidogrel, prasugrel, and ticagrelor with COR IB; whereas, ESC recommend prasugrel and ticagrelor with IB which is higher than clopidogrel with IC. CONCLUSION: This research addresses important movement to revise the Korean existing guideline recommendations. New Korean antiplatelet therapy guideline should be avoiding obvious differences in ACC/AHA and ESC guidelines and harmonizing international guidelines.
Acute Coronary Syndrome*
;
Aspirin
;
Cardiology
;
Europe*
;
Humans
;
Joints
;
Korea*
;
Prasugrel Hydrochloride